The Scientist explored the work of a researcher who had an unexpected finding while developing a novel anti-tau therapy.
A recent study published in Neurology explored whether high doses of nicotinamide, a derivative of vitamin B3, could reduce a ...
Ke Hou generated a compound that prevents tau aggregation in the murine brain, but the potential Alzheimer’s disease therapy ...
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder associated with a progressive decline in memory and ...
Plasma p-tau217 immunoassay offers accurate detection of Alzheimer’s disease pathology, supporting early diagnosis and ...
A ‘GAME-changing’ drug which could slow down Alzheimer’s disease is being considered for potential use on the NHS. The daily medication, called hydromethylthionine mesylate ...
Researchers from Washington University in St. Louis found people who took suvorexant, a common treatment for insomnia, for ...
“This subtype of Alzheimer’s includes the hallmark amyloid plaques and tau tangles—microscopic brain abnormalities used for ...
A study from Washington University in St. Louis found taking suvorexant, a common insomnia medication, for two nights ...
“This subtype of Alzheimer’s includes the hallmark amyloid plaques and tau tangles — microscopic brain abnormalities used for ...
It’s called asymptomatic Alzheimer’s. Nur Jury-Garfe, PhD, assistant research professor at the IU School of Medicine says when studied postmortem, these brains show beta-amyloid plaques and tau ...